AR
Adekunle Babajide Rowaiye
Also known as: Dr Row
National Biotechnology Development Agency, University of East London, Postgraduate College of Veterinary Surgeons of Nigeria
Research areas: Medicine · Infectious Diseases · SARS-CoV-2 and COVID-19 Research · Computational Drug Discovery Methods · Immunotherapy and Immune Responses
Employment
-
National Biotechnology Development Agency Deputy Director2011 - Present
Education
-
University of East London MSc Biotechnology2008 - 2009
-
Postgraduate College of Veterinary Surgeons of Nigeria Fellow College of Veterinary Surgeons of Nigeria
Projects & Funding
Projects & funding information is unavailable.
Publications (55)
- Vitamin B12 Deficiency in Sickle Cell Disease: Method‐Driven Estimates and Systematic Diagnostic Misclassification Save
- Exploring the mechanistic interplay between chronic high sugar consumption, gut microbiota, and Alzheimer's disease: Implications for drug discovery Save
- Care Delivery Gap framework: a proof-of-concept patient-reported measure of guideline-referenced care-process omissions in sickle cell disease Save
- Vitamin B12 Assessment in Sickle Cell Disease: A Systematic Evaluation of Diagnostic Validity and Misclassification Save
- Probiotics: An Emerging Tool against Pathogenic Bacteria Save
- Harnessing Viruses Against Multidrug‐Resistant Bacteria: Exploring the Potential of Bacteriophage‐Based Drug Discovery Save
- Antiaging products from marine sponges and their symbiotic microbes Save
- Nanotechnology in Combating Waterborne Antimicrobial Resistance Save
- Molecules of Therapeutic and Prophylactic Value in the Earthworm Save
- Phyto-molecules show potentials to combat drug-resistance in bacterial cell membranes Save
- The Potential of Biotoxins for Drug Discovery and Development Save
- Omega 3 in traditional medicine and its role in the treatment of Sickle Cell Disease complications Save
- Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature Save
- Bioactive Molecules of Medicinal Value in Marine Green Algae Save
- Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review Save
- Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications Save
- Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies Save
- Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery Save
- The NLRP3 inflammasome as a target for antiinflammatory drugs Save
- Immunomodulatory Benefits of Probiotic Bacteria: A Review of Evidence Save